Operating Expenses: The sum of all operating expenses for the given industry.
Novo Nordisk A/S (NVO) had Operating Expenses of $8.00B for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$12.21B |
|
$3.27B |
|
$2.66B |
|
$9.55B |
|
|
Operating Expenses |
$8.00B |
$4.21B |
|
$-28.94M |
|
$4.18B |
|
$4.18B |
|
$3.27B |
|
$3.27B |
|
$3.27B |
|
$3.27B |
|
$4.21B |
|
$5.81B |
|
4.44B |
|
4.44B |
|
$0.74 |
|
$0.74 |
|
| Balance Sheet Financials | |
$32.47B |
|
$36.06B |
|
$60.10B |
|
$92.57B |
|
$37.20B |
|
$18.95B |
|
$20.94B |
|
$58.14B |
|
$34.43B |
|
$15.44B |
|
$34.43B |
|
-- |
|
| Cash Flow Statement Financials | |
$12.34B |
|
$-3.81B |
|
$-5.69B |
|
$4.12B |
|
$6.92B |
|
$2.80B |
|
-- |
|
$-5.49B |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.87 |
|
-- |
|
-- |
|
0.35 |
|
0.63 |
|
78.21% |
|
34.48% |
|
34.48% |
|
-- |
|
34.24% |
|
26.74% |
|
$8.60B |
|
-- |
|
-- |
|
-- |
|
0.13 |
|
0.33 |
|
0.72 |
|
124.43 |
|
9.49% |
|
21.15% |
|
3.53% |
|
6.12% |
|
-- |
|
$1.94 |
|
$2.78 |
|